Host Cxcr2-dependent regulation of mammary tumor growth and metastasis

被引:0
作者
Bhawna Sharma
Kalyan C. Nannuru
Michelle L. Varney
Rakesh K. Singh
机构
[1] University of Wisconsin School of Medicine and Public Health,Department of Medicine, University of Wisconsin Carbone Cancer Center
[2] Regeneron Pharmaceuticals Inc.,Department of Pathology and Microbiology
[3] University of Nebraska Medical Center,undefined
来源
Clinical & Experimental Metastasis | 2015年 / 32卷
关键词
CXCR2; Angiogenesis; Metastasis; Inflammatory response; Chemokines;
D O I
暂无
中图分类号
学科分类号
摘要
Host-derived angiogenic and inflammatory tumor supportive microenvironment regulates progression and metastasis, but the molecular mechanism(s) underlying host-tumor interactions remains unclear. Tumor expression of CXCR2 and its ligands have been shown to regulate angiogenesis, invasion, tumor growth, and metastasis. In this report, we hypothesized that host-derived Cxcr2-dependent signaling plays an important role in breast cancer growth and metastasis. Two mammary tumor cell lines Cl66 and 4T1 cells were orthotopically implanted into the mammary fat pad of wild-type and Cxcr2−/− female BALB/c mice. Tumor growth and spontaneous lung metastasis were monitored. Immunohistochemical analyses of the tumor tissues were performed to analyze proliferation, angiogenesis, apoptosis and immune cell infiltration. Our results demonstrated that knock-down of host Cxcr2 decreases tumor growth and metastasis by reducing angiogenesis, proliferation and enhancing apoptosis. Host Cxcr2 plays an important role in governing the pro-inflammatory response in mammary tumors as evaluated by decreased Gr1+ tumor-associated granulocytes, F4/80+ tumor associated macrophages, and CD11b+Gr1+ myeloid derived suppressor cells in Cxcr2−/− mice as compared to control wild-type mice. Together, these results demonstrate that host Cxcr2-dependent signaling regulates mammary tumor growth and metastasis by promoting angiogenesis and pro-inflammatory responses.
引用
收藏
页码:65 / 72
页数:7
相关论文
共 239 条
  • [1] Siegel R(2013)Cancer statistics, 2013 CA Cancer J Clin 17 10-233
  • [2] Naishadham D(2008)Metastatic breast cancer: the treatment challenge Clin Breast Cancer 8 224-269
  • [3] Jemal A(2001)Seed and soil revisited: contribution of the organ microenvironment to cancer metastasis Surg Oncol Clin N Am 10 257-321
  • [4] Jones SE(2007)Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis Endocr Rev 28 297-379
  • [5] Fidler IJ(2001)The microenvironment of the tumour-host interface Nature 411 375-7162
  • [6] Langley RR(2004)Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival Clin Cancer Res 10 7157-84
  • [7] Fidler IJ(2003)Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients Rocz Akad Med Bialymst 48 82-808
  • [8] Liotta LA(2013)Targeting CXCR2 enhances chemotherapeutic response, inhibits mammary tumor growth, angiogenesis and lung metastasis Mol Cancer Ther 12 799-550
  • [9] Kohn EC(2004)Cancer and the chemokine network Nat Rev Cancer 4 540-144
  • [10] Benoy IH(2010)Chemokines and chemokine receptors: new insights into cancer-related inflammation Trends Mol Med 16 133-5277